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Summary.-Cells from the spleen, lymph node, peripheral blood and peritoneal
exudate of mice treated with C. parvum were tested for their ability to inhibit
tumour growth in vitro. The peritoneal exudate cells from C. parvum treated mice
were extremely effective in inhibiting tumour growth whereas the spleen and peri-
pheral blood cells were only moderately so. In contrast, the lymph node cells
caused only a modest inhibition of tumour growth at a very high effector to target
cell ratio. Spleen cells from normal mice also exerted a moderate anti-tumour
effect.
THE ANTI-TUMOUR effect of Coryne-
bacteriumn parvum has been repeatedly
demonstrated (Woodruff and Boak, 1966;
Halpern et al., 1966; Currie and Bagshaw,
1970; Woodruff, Dunbar and Ghaffar,
1973). In order to further elucidate the
mechanism underlying this phenomenon,
the effect oflymphoid cells from C. parvum
treated mice on the syngeneic mouse
fibrosarcoma cells has been studied in
vitro.
MATERIALS AND METHODS
illice.-CBA mice 7-9 weeks of age were
used as donors of both the tumour and the
effector cells in these experiments.
Tumour.- The tumour studied was a CBA
fibrosarcoma originally induced with methyl-
cholanthrene and now in its 15th transplant
generation.
Tumour cell cultures.-Tumour cell sus-
pensions were prepared from freshly excised
tumour by pronase digestion as described in a
previous communication (Woodruffand Boak,
1966). The cells were grown in vitro for at
least 10 days in the growth medium (RPMI-
1640 medium containing 10% foetal calf
serum (FCS), 2 mmol/l glutamine, 100 u peni-
cillin/ml and 100 ,tg streptomycin/ml) before
they were used in the cytotoxicity tests.
Effector cells. Mice were injected with
0-2 ml of 7 mg/ml C. parvum (Burroughs
Wellcome, WEZ 174) i.p. and spleen, lymph
nodes, peripheral bloodandperitoneal exudate
cells were obtained from these mice either 4
or 7 days thereafter. Mice of comparable
age and sex injected with phosphate buffered
saline served as donors of control cells.
Periph-eral blood leucocytes were obtained
from heparinized blood by the sedimentation
of red cells with plasma gel. The spleen and
lymph node cell suspensions were prepared by
gently disrupting the organs in a glass
homogenizer. Peritoneal exudate cells were
obtained by washing the peritoneal cavity of
anaesthetized mice with 5 ml of RPMI-1640
containing 10 u/ml of heparin. Various cell
suspensions were washed twice in the growth
medium, the cells were counted and adjusted
to a suitable concentration.
Removal ofglass adherent cells.-Peritoneal
exudate cells from mice treated with C.
parvum 4 days previously, or from control
mice were suspended in growth medium at a
concentration of 2-3 million cells/ml and 5-6
ml of this suspension was incubated at 37°C
in a glass medical flat lying on its side.
After a 30 min incubation the non-adherent
cells were decanted and centrifuged at 150 g.
This procedure resulted in a loss of 50% of
the cells from the control and 70% from theA. GHAFFAR, R. T. CULLEN, N. DUNBAR AND M. F. A. WOODRUFF
mice treated with C. parrum. The cells were
resuspended, counted and adjusted to the
required concentration.
Test systemt.-Tumour cells were suspended
in the growth medium containing additional
FCS (20% in toto) at a concentration of 25 x
103 cells/ml. 0-2 ml of this suspension was
seeded in each well of a disposable plastic
microculture plate (Linbro, IS-FB-96). The
plates were covered with a lid and incubated
overnight at 37°C in a humid atmosphere
containing 5co CO2. The medium wAas
removed from the wells on the follow-ing
morning and the desired number of lympho-
cytes or other cells, suspended in 0-2 ml
growth medium, were added to each wAell.
The plates were reincubated as before for
another 48 hours. At this stage the wvells
were again emptied, removing as many
lymphoid cells as possible without disturbing
the adherent tumour cells and refilled with 0-2
ml growth medium containing 0-25 HCi of
125Iodo-deoxyuridine (Radiochemical Centre,
Amersham, England). Following further
overnight incubation, the wells were gently
washed with Dulbecco's solution and dried.
The plates were sprayed writh Nobecutane
(BDH) and the individual wells were cut out
with a hot wire. The radioactivity incor-
porated into tumour cells was measured by
counting in a scintillation spectrometer. Each
experimental group consisted of 6-8 identical
cultures. A method similar to this has
been described recently by Seeger and OwAen
(1973).
Presentation of results.-The results have
been expressed as the geometric mean of
counts per minute (ct/min) from 6-8 cultures
with the limits of one standard error. The
cytotoxicity index (CI) was calculated from
the formula
CI _ (N -T) x 100
N
where N = mean count in cultures containing
effector cells from control (unstimulated)
mice and T = mean count in cultures con-
taining similar cells from mice treated with
C. parvurn.
P values were calculated by the standard
two-tail Student's ' t " test.
RESULTS
The data listed in Tables I-IV clearly
indicate that cells from peritoneal exudate,
peripheral blood, spleen and lymph nodes
from mice treated with C. parvrum in-
hibited tumour growth in vitro. It should,
TABLE I. Anti-tumour Effect ofPeritoneal Exudate Cells from Mice
Treated with C. Parvum
Effector
Days target
after cell
treatment ratio
80 : 1
40: 1
4 20 : I
None
80: 1
40 : 1
20: 1
7 10:1
5 : N
NTone
Ct/min
Normal (N)
3153 (2981-3335)
(7)*
11790 (11306-12295)
(7)
18064 (16569-19693)
(7)
11913 (10934-12981)
(10)
8813 (8058-9637)
(7)
13732 (13024-14479)
(7)
14204 (130:18--1547:3)
(7)
14199 (123153-16320)
(7)
13418 (12693-14183)
(7)
9605 (8423-10953)
(10)
* No. of cultures per grotup.
C. parvurn
tireated( (T)
256 (235-280)
(7)
:3:35 (311-405)
(7)
366 (317-424)
(8)
251 (240-261)
(7)
275 (262--288)
(7)
:308 (285-333)
(7)
391 (371-412)
(7)
933 (868-1003)
(7)
Cytotoxic
in(lex
92
t test comparison
of gr'oups N an(l T
t P
24*206 <0*001
97 25 - 269 <0 001
98 22-7171 <0 001
97 36- 1639 < 0-001
98 54* 9376 <0 * 001
98 39-5387 <0 001
97 24-1371 <0 001
93 29 * 4369 <0 * 001
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however, be noted that cells obtained from
different organs varied considerably in
their effectiveness in inhibiting the tumour
growth. Thus, peritoneal exudate cells
from C. par-vum treated animals caused a
complete inhibition of tumour cell growth
over a range of effector to target cell ratio
of 80: 1 to 5: 1 (Table I). Peripheral
blood leucocytes did not cause nearly such
drastic inhibition even at the very high
(80: 1) effector to target cell ratio (Table
II). Spleen cells from C. parvurn treated
animals (Table III) exerted an anti-
tumour effect usually comparable with but
sometimes greater than, that exerted by
peripheral blood leucocytes. In contrast
with peritoneal exudate, peripheral blood
and spleen cells, the lymph node cells from
C. parvurn treated mice exhibited very
little anti-tumour effect and caused only a
modest inhibition oftumour growth at the
very high (400: 1) effector to target cell
ratio (Table IV).
From a direct comparison of anti-
tumour activity of different cell popula-
tions obtained at two different times after
C. parvum treatment, there is some sugges-
tion that the anti-tumour activity in
spleen (Table III) and lymph nodes
(Table IV) increased with time whereas
that in the peripheral blood (Table II)
decreased. No obvious change in the
anti-tumour activity ofperitoneal exudate
cells was noted over this period (Table I).-
The data listed in Table V clearly
indicate that the tumour inhibitory pro-
perty of peritoneal exudate cells is
drastically reduced when the cells are
incubated on glass at 37°C for 30 min. At
no concentration did the incubated peri-
toneal exudate cells from C. parvum
treated mice cause a significant inhibition
of in vitro tumour growth.
Finally, it should be noted that spleen
cells from normal mice also showed a
strong anti-tumour effect (Tables III and
IV). However, the lymph node, peri-
pheral blood and peritoneal exudate cells
from normal mice did not have a very
significant effect on the tumour growth.
DISCUSSION
The observations reported here provide
in vitro evidence of a direct action of
TABLE II. Anti-tumour Effect ofPeripheral Blood Cells from Mice Treated
with C. Parvum
Effector
Days target
after cell
treatment ratio
80 : 1
40 : 1
4 20:1
10 : 1
None
80 : 1
40 : 1
7
20 : 1
None
Ct/min
Normal (N)
-24436)
-26731)
-29036)
-28107)
-37835)
-19.326)
-24325)
-27781)
-26387)
22668 (21029-
(5)*
25737 (24780-
(7)
27618 (26270-
(7)
26887 (25721-
(7)
36783 (35760-
(12)
17364 (15602-
(7)
23325 (22365-
(8)
26237 (24779-
(8)
24754 (23222-
(15)
C,. porvuom
treated (T)
9345 (7952-10981)
(7)
19210 (18424-20029)
(7)
23206 (22263-24190)
(7)
27233 (26275-28226)
(7)
10889 (9630-12313)
(8)
18794 (16447-21476)
(8)
22028 (20732-23404)
(8)
Cytotoxic
index
52
t test comparison
of groups N an(l T
t P
4-3572 <0 005
25 5-1857 <0-001
16 2-6764 <0025
-1 0-2244 >0-8
37 2-828 <0-02
24 1-546 >0- 10
16 2-095 >0-05
* No. of cultures per group.
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TABLE IV.-Anti-tumour Effect of Lymph Node Cellsfrom Mice Treated
with C. Parvum
Effector
Days target
after cell
treatment ratio
400: 1
200: 1
4 100:1
50 : 1
None
400: 1
200 : 1
7
100: 1
None
Ct/min
Normal (N)
28214 (27213-29253)
(6)*
29076 (27824-30385)
(7)
29787 (28728-30886)
(7)
28591 (27203-30050)
(7)
27773 (26046-29614)
(12)
22620 (21814-23454)
(6)
24050 (21802-26530)
(8)
30785 (28188-33621)
(8)
27779 (26083-29585)
(16)
C. parvum
treated (T)
21969 (21375-22579)
(7)
24442 (23806-25096)
(7)
26234 (24691-27873)
(7)
27243 (26197-28331)
(7)
11724 (10930-12577)
(8)
19378 (18006-20855)
(8)
24473 (24258-26749)
(8)
Cytotoxic
index
22
16
11
5
48
19
17
t test comparison
of groups N and T
t P
5-6401 <0-001
3 - 3912 <0-01
1-8057 >0*05
0-7621 >0*40
7 530 <0*001
1-766 >0 05
1-877 >0*05
* No. of cultures per group.
lymphocytes and/or macrophages from C.
parvum treated mice on tumour cells in
vitro and are complementary to the in vivo
studies referred to in the introductory
paragraph.
A number of observations have been
reported which clearly point to the role of
macrophages in tumour cell destruction
both in vivo and in vitro (Den Otter,
Evans and Alexander, 1972; Hibbs,
Lambert and Remington, 1972; Keller
and Hess, 1972). Furthermore, the ob-
servations from this laboratory indicating
the relatively slower growth of methyl-
cholanthrene induced fibrosarcomata in T
cell deprived mice and the inhibition of
tumour growth in these mice by C. parvum
lend further support for the view that
macrophages play an important role in
tumour cell destruction (Woodruff et al.,
1973). Considering the existing evidence
forthe powerfulactionofC.parvuminstim-
ulating the reticuloendothelial system
(Halpern et al., 1964; Smith and Woodruff,
1968; Collet, 1971; Adlam and Scott, 1973;
O'Neill, Henderson and White, 1973), it is
tempting to speculate that the anti-
tumour effect of various cells from C.
parvum treated mice observed here may be
mediated by the macrophage contents of
these cell populations. The relatively
high efficiency of peritoneal exudate cells
in inhibiting the tumour growth in vitro
supports this view. Furthermore, the
removal of the anti-tumour activity from
the peritoneal exudate cells from C.
parvum treated mice by incubation on
glass surfaces provides a strong evidence
for macrophages being responsible for the
inhibition of the tumour growth in vitro.
From the anti-tumour (70% inhibi-
tion) effect of normal peritoneal exudate
cells at the very highest effector to target
cell ratio (80: 1) in one experiment
(Table I) it might be suspected that the C.
parvum treatment merely increased the
number ofmacrophages in the effector cell
population but this seems an unlikely
explanation. In our experiments the
glass adherent cells in the peritoneal
exudate from C. parvum treated animals
increased only to 70% compared with 50%
glass adherent cells in the peritoneal
exudate from non-treated animals, and in
order to account for a 90% inhibition by
the peritoneal exudate cells from C.
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parvum treated mice at a ratio of 5: 1
(Table I) one would have to postulate an
astronomical 16-fold increase in the macro-
phage population in the peritoneal exudate
cells from C. parvum treated animals.
This is obviously far more than could be
achieved even if all the cells in peritoneal
exudate of C. parvum treated mice were
macrophages. Further studies are, how-
ever, in progress to test the effect of
purified macrophages from C. parvum
treated and normal animals on tumour cell
growth in vitro.
In these studies only tumour cells
were used as the target. It should there-
fore be stressed that the aggressor activity
of the macrophages from C. parvum
treated mice may not necessarily be
restricted only to tumour cells. Indeed,
there is some evidence that macrophages
from C. parvum treated animals will
damage normal syngeneic fibroblastic cells
(McBride and Taylor, personal com-
munication).
While the results reported here con-
vincingly demonstrate the anti-tumour
effects oflymphoid and peritoneal exudate
cells from C. parvum treated mice, and the
evidence presented strongly indicates the
involvement of macrophages as effector
cells, the complementary role ofother cells
cannot be categorically excluded. Fur-
ther studies are therefore being carried out
to confirm the role ofmacrophages and the
possible involvement of other cells from
C. parvum treated mice in the inhibition of
tumour growth both in vitro and in vivo.
The mechanism by which the macro-
phages acquire the anti-tumour activity is
at present unknown. It is conceivable
that they underwent a process similar to
the " arming " described by Evans and
Alexander (1972) but this would require
the presence of significant amounts of C.
parvum antigens brought over by the
macrophages into the culture system.
Experiments to test this hypothesis are
also in progress.
The authors wish to thank the Well-
come Foundation for providing the C.
parvum suspension and the Cancer Re-
search Campaign for the generous financial
support.
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